NovaBay Pharmaceuticals, Inc. (NBY) is a publicly traded Healthcare sector company. As of May 21, 2026, NBY trades at $1.95 with a market cap of $51.92M and a P/E ratio of 0.12. NBY moved +23.42% today. Year to date, NBY is -62.14%; over the trailing twelve months it is -31.82%. Its 52-week range spans $1.11 to $99.75. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces NBY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NovaBay Pharmaceuticals, Inc. (NBY) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NBY moved +23.42% today. Analyst consensus is hold.
| Metric | Value |
|---|---|
| Price | $1.95 |
| Market Cap | $51.92M |
| P/E Ratio | 0.12 |
| EPS | $16.10 |
| Dividend Yield | 0.80% |
| 52-Week High | $99.75 |
| 52-Week Low | $1.11 |
| Volume | 637.60K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.46M |
| Net Income | $522.59M |
| Gross Margin | 0.00% |
5 analysts cover NBY: 0 strong buy, 2 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.